国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Global EditionASIA 中文雙語(yǔ)Fran?ais
Business
Home / Business / Companies

AstraZeneca announces medical AI cooperation with Chinese companies

By ZHENG YIRAN | chinadaily.com.cn | Updated: 2020-07-02 16:25
Share
Share - WeChat
The AstraZeneca logo. [Photo/astrazeneca.com.cn]

During the upcoming 2020 World Artificial Intelligence Conference in Shanghai, United Kingdom-based pharmaceutical company AstraZeneca said it will launch 10 major application scenarios integrating AI with healthcare, further boosting its cooperation in innovation with Chinese companies, said a senior official.

Leon Wang, executive vice-president and China president at AstraZeneca, said for the 2020 WAIC, which will be held between July 9 and 11, the company will reveal the latest applications of AI in the healthcare sector, covering scenarios including pharmaceutical research and development, drug production, diagnosis and treatment, and the company is open to cooperation opportunities with Chinese firms.

"Through the cooperation, with the help of advanced technologies such as machine vision, prediction algorithms and natural language understanding, we hope to explore deeply into the processes including screening, diagnosis, treatment and patient follow-up. In this way, we are able to promote the application of AI in various diseases, fully increase work efficiency and benefit Chinese patients better," he said.

It is estimated the company may announce the cooperation and innovative achievements by the WAIC next year, he added.

To foster innovative cooperation with Chinese companies, with the help of the local government, last year AstraZeneca built the Wuxi International Life Science Innovation Campus in Wuxi, Jiangsu province. According to the company, it plans to launch more life science innovation campuses in more cities in the future, including Beijing, Shanghai, Guangzhou, Chengdu and Hangzhou.

Working with China International Capital Corp Ltd, AstraZeneca launched a medical fund worth $1 billion. The fund was raised to invest in medical innovation in China.

Currently, the first phase of fundraising is completed. It is estimated the fund will start to use this year to assist Chinese innovative enterprises, Wang said.

CICC said AI is changing the world, and has become an inevitable trend. The company will focus on the latest application of AI and promote the exploration and landing of applications.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
祁阳县| 潮安县| 平安县| 柞水县| 福贡县| 建始县| 屏南县| 阿巴嘎旗| 抚松县| 介休市| 迭部县| 夏津县| 调兵山市| 恭城| 屏山县| 玉环县| 横山县| 阳西县| 右玉县| 荥经县| 阜新市| 宾川县| 德惠市| 云浮市| 阿合奇县| 石狮市| 大邑县| 宝坻区| 祁东县| 伊宁市| 嘉定区| 长沙县| 白银市| 桦川县| 湘潭市| 瓮安县| 高碑店市| 获嘉县| 达州市| 玉门市| 时尚|